Omega Healthcare Investors Inc (OHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $14.98B
Last updated: Nov 17, 2026 at 4:39 PM ET
Omega Healthcare Investors Inc (OHI) Statistics
Omega Healthcare Investors (OHI) has a market cap of $14.98B and a P/FFO of 14.0x on its 2026 FFO estimate. It kept 68.14% of revenue as net income over the last 12 months. Revenue grew 40.64% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 26.60% above the market cap, as debt exceeds cash.
| Market Cap | $14.98B |
|---|---|
| Enterprise Value | $18.97B |
| Latest price (Nov 17, 2026) | $46.79 |
Key Dates
The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 5, 2026.
| Next Earnings Date | Feb 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Last Ex-Dividend Date | Nov 5, 2026 |
| Last Payment Date | Nov 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 14.0x on the 2026 FFO estimate of $3.35 a share. Its year-end P/S ranged from 3.6x to 13.2x from 2016 to 2025.
| P/FFO (2026 estimate) | 14.0x |
|---|---|
| P/E Ratio | 17.6x |
| Forward P/E | 18.2x |
| P/S Ratio | 10.8x |
| Forward P/S | 13.4x |
| P/B Ratio | 2.6x |
| P/TBV Ratio | 3.0x |
| P/FCF Ratio | 17.4x |
| P/OCF Ratio | 16.8x |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.1x EBITDA and 22.3x free cash flow.
| EV / Earnings | 21.2x |
|---|---|
| EV / Sales | 14.4x |
| EV / EBITDA | 15.1x |
| EV / FCF | 22.3x |
Price Statistics
The stock is up 8.01% over 52 weeks and trades 1.94% above its 50-day average.
| Beta (1Y) | -0.15 |
|---|---|
| 52-Week Change | +8.01% |
| 1-Month Change | +5.71% |
| 3-Month Change | +1.14% |
| 6-Month Change | -2.67% |
| 5-Year Change | +60.01% |
| 10-Year Change | +47.60% |
| Total Return (1Y) | +14.24% |
| Total Return (3Y CAGR) | +19.10% |
| Total Return (5Y CAGR) | +16.82% |
| Return vs SPY (1Y) | -6.31% |
| Max Drawdown (1Y) | -14.24% |
| Max Drawdown (3Y) | -14.24% |
| Sharpe Ratio (1Y) | 0.24 |
| Correlation with SPY (1Y) | -0.10 |
| 50-Day Average | $45.90 |
| 200-Day Average | $45.99 |
| 52-Week Range | $39.85 to $50.97 |
| RSI (14 Days) | 51.1 |
| Average Volume (20 Days) | 2.26M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 0.75x shareholder equity.
| Debt / Equity | 0.75x |
|---|---|
| Debt / EBITDA | 3.34x |
| Debt / FCF | 4.93x |
| Interest Coverage | 4.19x |
Returns and Efficiency
Return on invested capital is 9.08% over the last 12 months, against a 5-year average of 4.52%.
| Return on Equity (ROE) | 16.61% |
|---|---|
| Return on Assets (ROA) | 8.94% |
| Return on Invested Capital (ROIC) | 9.08% |
| ROE (5Y Average) | 10.21% |
| ROA (5Y Average) | 4.42% |
| ROIC (5Y Average) | 4.52% |
| Asset Turnover | 0.13x |
Taxes
Income tax took 1.81% of pretax income over the last 12 months.
| Income Tax (TTM) | $16.33M |
|---|---|
| Effective Tax Rate | 1.81% |
Scores
OHI has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $3.11 for 2025, the latest reported year. Revenue was $1.31B over the last 12 months.
| FFO Per Share (2025) | $3.11 |
|---|---|
| Revenue | $1.31B |
| Revenue Growth (YoY) | +40.64% |
| Pretax Income | $902.32M |
| Net Income | $895.17M |
| EBITDA | $1.21B |
| Reported EPS (TTM) | $2.66 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 53.85% of the $10.01B in total assets.
| Cash and Equivalents | $39.04M |
|---|---|
| Total Debt | $4.02B |
| Net Debt | $3.99B |
| Net Debt Per Share | $13.15 |
| Shareholder Equity | $5.39B |
| Book Value Per Share | $17.79 |
| Tangible Book Value | $4.75B |
| Tangible Book Per Share | $15.66 |
| Total Assets | $10.01B |
| Total Liabilities | $4.37B |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $74.60M of capital spending, operating cash flow left $815.96M of free cash flow.
| Operating Cash Flow | $890.56M |
|---|---|
| Capital Expenditures | $74.60M |
| Free Cash Flow | $815.96M |
| FCF Per Share | $2.69 |
| Depreciation and Amortization | $341.20M |
| Dividends Paid | $845.36M |
Trailing 12 months through Jun 30, 2026.
Margins
| Pretax Margin | 68.68% |
|---|---|
| Net Margin | 68.14% |
| EBITDA Margin | 91.83% |
| FCF Margin | 62.11% |
| Operating Margin (5Y Average) | 64.83% |
| Net Margin (5Y Average) | 47.77% |
Growth
FFO per share fell 2.06% a year over 3 years, and revenue 1.00% a year.
| FFO Per Share Growth (3Y CAGR) | -2.06% |
|---|---|
| Revenue Growth (3Y CAGR) | -1.00% |
| Revenue Growth (5Y CAGR) | +7.22% |
| EPS Growth (3Y CAGR) | -0.81% |
| EPS Growth (5Y CAGR) | +14.53% |
| FCF Growth (3Y CAGR) | +11.30% |
| FCF Growth (5Y CAGR) | +5.79% |
| Operating Income Growth (3Y CAGR) | +24.08% |
| Book Value Per Share Growth (2Y CAGR) | +8.96% |
| Tangible Book Per Share Growth (2Y CAGR) | +12.60% |
Dividends and Yields
OHI pays out 87.46% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $2.72 |
|---|---|
| Dividend Yield | 5.81% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | 0.00% |
| Payout Ratio (2025 FFO) | 87.46% |
| FCF Payout Ratio | 103.60% |
| FFO Yield (2025) | 6.65% |
| FCF Yield | 5.76% |
| Buyback Yield | -1.80% |
| Shareholder Yield | 4.16% |
Peer Position
Against 12 similar companies, OHI has the 5th highest P/FFO and the 3rd highest P/S.
P/FFOPeer median 11.7x
P/S RatioPeer median 5.5x
ROICPeer median 3.33%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +20.50%
Dividend YieldPeer median 5.78%
| P/FFO | 14.0x vs 11.7x median |
|---|---|
| P/S Ratio | 10.8x vs 5.5x median |
| ROIC | 9.08% vs 3.33% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +40.64% vs +20.50% median |
| Dividend Yield | 5.81% vs 5.78% median |
Analyst Forecast
FFO per share estimates imply 5.63% growth a year over the next 2 years. Consensus estimates put revenue growth at 11.32% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +5.63% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +11.32% |
| EPS Growth Forecast (2Y CAGR) | +0.39% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OHI
What is OHI's market cap?
Omega Healthcare Investors has a market cap of $14.98B. Its enterprise value, which adds debt and subtracts cash, is $18.97B.
What is OHI's P/E ratio?
Omega Healthcare Investors has a P/FFO of 14.0x on its 2026 FFO estimate. Its trailing P/E ratio is 17.6x and its forward P/E is 18.2x.
How many shares of OHI are outstanding?
Omega Healthcare Investors has 303.01M shares outstanding. The count is up 2.72% from a year earlier.
Does OHI pay a dividend?
Yes. Omega Healthcare Investors pays $2.72 a share a year, a dividend yield of 5.81%.
How much debt does OHI have?
Omega Healthcare Investors has $4.02B of total debt and $39.04M of cash and equivalents, a net debt position of $3.99B.
OHI pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors